Skip to main content
logo
Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
68.10
+1.16 (1.73%)
At close: Feb 6, 2026, 4:00 PM EST
69.06
+0.96 (1.41%)
After-hours: Feb 6, 2026, 7:49 PM EST

Arcellx Revenue

Arcellx had revenue of $4.95M in the quarter ending September 30, 2025, a decrease of -80.99%. This brings the company's revenue in the last twelve months to $35.90M, down -76.96% year-over-year. In the year 2024, Arcellx had annual revenue of $107.94M, down -2.16%.

Revenue (ttm)
$35.90M
Revenue Growth
-76.96%
P/S Ratio
104.94
Revenue / Employee
$220,233
Employees
163
Market Cap
3.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024107.94M-2.38M-2.16%
Dec 31, 2023110.32M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ACADIA Pharmaceuticals1.05B
Corcept Therapeutics741.17M
TG Therapeutics531.90M
ADMA Biologics488.56M
Ligand Pharmaceuticals251.23M
Liquidia69.22M
NewAmsterdam Pharma Company35.24M
Centessa Pharmaceuticals15.00M
Revenue Rankings

ACLX News

More News